OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

iTRAQ-based proteomics for studying the effects of dioscin against nonalcoholic fatty liver disease in rats
Lina Xu, Yongli Wei, Deshi Dong, et al.
RSC Advances (2014) Vol. 4, Iss. 58, pp. 30704-30704
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation
Yimeng Zhang, Youwei Xu, Yan Qi, et al.
Toxicology (2017) Vol. 378, pp. 53-64
Closed Access | Times Cited: 130

Dioscin: A diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections
Xufeng Tao, Lianhong Yin, Lina Xu, et al.
Pharmacological Research (2018) Vol. 137, pp. 259-269
Closed Access | Times Cited: 119

Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries
Qingsheng Liu, Ran Pan, Lei Ding, et al.
International Immunopharmacology (2017) Vol. 49, pp. 132-141
Closed Access | Times Cited: 116

Phytosterols and their derivatives: Potential health‐promoting uses against lipid metabolism and associated diseases, mechanism, and safety issues
Simin Feng, Tarun Belwal, Li Li, et al.
Comprehensive Reviews in Food Science and Food Safety (2020) Vol. 19, Iss. 4, pp. 1243-1267
Open Access | Times Cited: 104

Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway
Li-Na Gu, Xufeng Tao, Youwei Xu, et al.
Toxicology and Applied Pharmacology (2015) Vol. 292, pp. 19-29
Closed Access | Times Cited: 99

Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway
Hong Yao, Xufeng Tao, Lina Xu, et al.
Pharmacological Research (2018) Vol. 131, pp. 51-60
Closed Access | Times Cited: 95

Protective effects of dioscin against cisplatin-induced nephrotoxicity via the microRNA-34a/sirtuin 1 signalling pathway
Yimeng Zhang, Xufeng Tao, Lianhong Yin, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 15, pp. 2512-2527
Open Access | Times Cited: 93

Potent effects of dioscin against obesity in mice
Min Liu, Lina Xu, Lianhong Yin, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 90

Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70
Meng Qi, Lingli Zheng, Yan Qi, et al.
Pharmacological Research (2015) Vol. 100, pp. 341-352
Closed Access | Times Cited: 82

Potent effects of dioscin against liver fibrosis
Xiaoling Zhang, Xu Han, Lianhong Yin, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 82

Dioscin alleviates lipopolysaccharide-induced inflammatory kidney injury via the microRNA let-7i/TLR4/MyD88 signaling pathway
Meng Qi, Lianhong Yin, Lina Xu, et al.
Pharmacological Research (2016) Vol. 111, pp. 509-522
Closed Access | Times Cited: 82

Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway
Hong Yao, Changsheng Hu, Lianhong Yin, et al.
International Immunopharmacology (2016) Vol. 36, pp. 132-141
Closed Access | Times Cited: 79

Effect and possible mechanisms of dioscin on ameliorating metabolic glycolipid metabolic disorder in type-2-diabetes
Li Xu, Lianhong Yin, Yue Jin, et al.
Phytomedicine (2019) Vol. 67, pp. 153139-153139
Closed Access | Times Cited: 61

Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo
Lingli Zheng, Lianhong Yin, Lina Xu, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 97, pp. 481-488
Closed Access | Times Cited: 53

Potent effects of dioscin against gastric cancer in vitro and in vivo
Xinwei Zhao, Lina Xu, Lingli Zheng, et al.
Phytomedicine (2016) Vol. 23, Iss. 3, pp. 274-282
Closed Access | Times Cited: 50

Dioscin alleviates dimethylnitrosamine-induced acute liver injury through regulating apoptosis, oxidative stress and inflammation
Weixin Zhang, Lianhong Yin, Xufeng Tao, et al.
Environmental Toxicology and Pharmacology (2016) Vol. 45, pp. 193-201
Closed Access | Times Cited: 47

Dioscin reduces ovariectomy-induced bone loss by enhancing osteoblastogenesis and inhibiting osteoclastogenesis
Xufeng Tao, Yan Qi, Lina Xu, et al.
Pharmacological Research (2016) Vol. 108, pp. 90-101
Closed Access | Times Cited: 44

iTRAQ-based proteomics monitors the withering dynamics in postharvest leaves of tea plant (Camellia sinensis)
Zhijun Wu, Hongyu Ma, Jing Zhuang
Molecular Genetics and Genomics (2017) Vol. 293, Iss. 1, pp. 45-59
Closed Access | Times Cited: 42

Quantitative chemical proteomics for investigating the biomarkers of dioscin against liver fibrosis caused by CCl4 in rats
Xiaoling Zhang, Lina Xu, Lianhong Yin, et al.
Chemical Communications (2015) Vol. 51, Iss. 55, pp. 11064-11067
Closed Access | Times Cited: 39

Sechium edule Shoot Extracts and Active Components Improve Obesity and a Fatty Liver That Involved Reducing Hepatic Lipogenesis and Adipogenesis in High-Fat-Diet-Fed Rats
Mon‐Yuan Yang, Kuei‐Chuan Chan, Yi‐Ju Lee, et al.
Journal of Agricultural and Food Chemistry (2015) Vol. 63, Iss. 18, pp. 4587-4596
Closed Access | Times Cited: 30

Dioscin, a potent ITGA5 inhibitor, reduces the synthesis of collagen against liver fibrosis: Insights from SILAC-based proteomics analysis
Lina Xu, Lianhong Yin, Xufeng Tao, et al.
Food and Chemical Toxicology (2017) Vol. 107, pp. 318-328
Closed Access | Times Cited: 27

Curative effect of arjunolic acid from Terminalia arjuna in non-alcoholic fatty liver disease models
Erenius Toppo, S. Sylvester Darvin, S. Esakkimuthu, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 107, pp. 979-988
Closed Access | Times Cited: 24

Potential hepatoprotective effects of fullerenol nanoparticles on alcohol-induced oxidative stress by ROS
Yuanman Li, Haibo Luo, Hongyan Zhang, et al.
RSC Advances (2016) Vol. 6, Iss. 37, pp. 31122-31130
Closed Access | Times Cited: 23

Page 1 - Next Page

Scroll to top